Equity Research Senior Associate, Biopharma

Job Description

An exciting opportunity to join a leading investment bank's Equity Research team as a Senior Associate covering the Biopharma sector in New York City.

\n

\n

This is an opportunity to work closely with a highly regarded research team, developing differentiated investment views across the biopharmaceutical landscape. The role offers significant exposure to company management teams, institutional investors, and the broader investment community, with the opportunity to contribute directly to high-impact research and investment ideas.

\n

\n

Key Responsibilities

\n

\n
• Conduct fundamental research and financial analysis on publicly traded biopharmaceutical companies.
\n
• Build and maintain detailed financial models, valuation frameworks, and earnings forecasts.
\n
• Analyze clinical trial data, drug pipelines, regulatory developments, competitive dynamics, and commercial opportunities to assess company fundamentals.
\n
• Develop differentiated investment insights and communicate findings through in-depth research reports, earnings updates, and investment recommendations.
\n
• Engage with company management teams, industry experts, and institutional investors to deepen sector knowledge and identify emerging trends.
\n
• Support the development of investment theses and contribute to the team's broader research strategy.
\n

\n

\n

What They're Looking For

\n

\n
• Experience in equity research, ideally with a focus on Biopharma or Biotechnology.
\n
• Strong financial modelling, valuation, and analytical skills.
\n
• A solid understanding of drug development, clinical trial readouts, regulatory pathways, and biopharma commercial dynamics.
\n
• The ability to interpret complex scientific and financial information and translate it into clear, actionable investment insights.
\n
• Strong written and verbal communication skills, with the ability to thrive in a fast-paced, intellectually rigorous environment.
\n
• A PhD, MD, or relevant scientific background would be advantageous, but is not essential.
\n

\n

\n

Why Consider This Opportunity?

\n

Join a high-calibre research platform where rigorous fundamental analysis, deep sector expertise, and differentiated thinking drive the investment process. This is an opportunity to deepen your expertise across Biopharma, build relationships across the investment community, and take on meaningful responsibility within an established research franchise.